Clinical Trial Update: A Study to Evaluate the Effects of SB-751689 or rhPTH(1-34) on Excretion of Calcium and Phosphate in Women [Phase 1]

View source ↗

Summary

Phase 1 study by GlaxoSmithKline comparing SB-751689 and rhPTH(1-34) on calcium and phosphate excretion in women with osteoporosis. The trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• SB-751689 (SB-751689)
• rhPTH(1-34) (teriparatide)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Osteoporosis | Phase 1 | Status: COMPLETED